EMA401: an old antagonist of the AT2R for a new indication in neuropathic pain
Jan M Keppel Hesselink,1 Michael E Schatman2 1Institute of Neuropathic Pain, Bosch en Duin, the Netherlands; 2Department of Public Health and Community Medicine, Tufts University School of Medicine, Boston, MA, USA Abstract: EMA401 is an old molecule, synthesized by Parke-Davis in the last century a...
Main Authors: | Keppel Hesselink JM, Schatman ME |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2017-02-01
|
Series: | Journal of Pain Research |
Subjects: | |
Online Access: | https://www.dovepress.com/ema401-an-old-antagonist-of-the-at2r-for-a-new-indication-in-neuropath-peer-reviewed-article-JPR |
Similar Items
-
Repositioning of the Angiotensin II Receptor Antagonist Candesartan as an Anti-Inflammatory Agent With NLRP3 Inflammasome Inhibitory Activity
by: Wen-Yu Lin, et al.
Published: (2022-05-01) -
Topical phenytoin for the treatment of neuropathic pain
by: Kopsky DJ, et al.
Published: (2017-02-01) -
PERKEMBANGANGADAI EMAS KE INVESTASI EMAS PADA PEGADAIAN SYARIAH
by: Nunung Uswatun Habibah
Published: (2017-02-01) -
ANGIOTENSIN II RECEPTOR ANTAGONISTS AND PROTEINURIA
by: Tanja Kök, et al.
Published: (2002-03-01) -
EMA401, an angiotensin II type 2 receptor antagonist blocks visceral hypersensitivity and colonic hyperpermeability in rat model of irritable bowel syndrome
by: Tsukasa Nozu, et al.
Published: (2021-07-01)